|
EyeDoc - Laser
|
|
|
Key Benefits
The PMIS Computerized Ophthalmic Laser Report System, EyeDoc-Laser, provides a unique ophthalmology interface that has been designed by a team of a practicing ophthalmologist and a computer scientist to meet the specific needs and demands of ophthalmologists both in private practice and academia. The EyeDoc-Laser is a user friendly computerized documentation system that generates automated laser reports within seconds of completion of laser procedure. Its goal is to increase the efficiency and productivity of the practice as well as improve the degree and ease of documentation. It provides a separate clinical template for each of the various laser procedures. It utilizes a user-friendly and intuitive data entry system where with a few button clicks, it is possible to generate detailed operative reports. The automated reports cover the patient demographics, pre-operative and post-operative diagnoses, the indications, risks, benefits, alternatives, and possible complications of the procedure, the type of laser wavelength, anesthesia and contact lens used, the procedure performed with the laser settings for spot size, duration, power setting, and total number of burns as well as follow up instructions. In addition, several of the templates have comments sections to discuss in more detail the distribution and limitations of the treatment as well as rich graphics capabilities to draw the findings and treatment patterns in color as desired. Within a few seconds, the automated laser report is generated. This can be edited as desired and printed. The EyeDoc-Laser is customizable to encompass the specific laser procedures done by the various ophthalmologists in the practice. Each surgeon can also alter the specific wordings as desired within the templates. Thus, it provides automated, legible, accurate, comprehensive, laser operative reports that are generated by the time patient is ready to leave the laser room. It also has mail and fax capabilities as well as the option to interface with other ophthalmic equipment and digital cameras. Thus, not only does it allow for immediate access and documentation of data, but also cuts down the overhead cost associated with expenses of transcriptionists. This puts the practice in a favorable position in face of todays more challenging environment with HCFA mandates and utilization reviews, claims reviews and payments, and decreases the risk of documentation errors.
EyeDoc Ophthalmology Associates Operative Report
Name: Alan, Jim C. Date of Birth: 3/1/1963 Date of Procedure: 5/26/1997 Preoperative Diagnosis: High risk proliferative diabetic retinopathy, left eye Postoperative Diagnosis: High risk proliferative diabetic retinopathy, left eye Procedure Performed: Panretinal photocoagulation, left eye, session 1 Surgeon: U. Eyedoc, M.D. Anesthesia: Topical Anesthesia: Topical
Indications: This is a 34-year-old white male with high risk proliferative diabetic retinopathy of the left eye. On examination, he was found to have vitreous hemorrhage and neovascularization of the disc > 10A. Thus, findings, results, and recommendations of the Diabetic Retinopathy Study and the Early Treatment Diabetic Retinopathy Study were discussed with the patient. The risks, benefits, alternatives, side effects, and possible complications of panretinal photocoagulation including reduced central vision, decreased night vision, decreased peripheral vision and accommodation, foveal burn or macular edema, choroidal effusion, serous retinal detachment, glaucoma, rupture of Bruch's membrane, subretinal neovascular membrane formation, corneal burn, and poorly reactive pupil were discussed with the patient. He understood and wished to proceed. Informed consent was obtained. In addition, we discussed prognosis, and possible need for further laser treatment(s) in the future. Procedure: The patient was brought to the laser suite. He was identified visually and verbally by the surgeon. A drop of Mydriacil 0.5% and phenylephrine 2.5% were instilled into the left eye. Topical tetracaine was used for anesthesia. Then, using the Argon green laser at 500 micron spot size, 400-700mW of power, 0.1 second duration, 505 burns were placed in panretinal distribution using Goldmann pancake and Goldmann 3-mirror lens(es). Overall, the treatment was limited secondary to vitreous hemorrhage. There were no complications. He is to return to clinic in 10 day(s) for follow-up evaluation and further laser treatment.
U. Eyedoc, M.D.
For information please contact info@PennMedical.com
Send mail to webmstr@pennmedical.com with
questions or comments about this web site.
|